Gene: APOBEC3G
Official Full Name: apolipoprotein B mRNA editing enzyme catalytic subunit 3Gprovided by HGNC
Gene Summary: This gene is a member of the cytidine deaminase gene family. It is one of seven related genes or pseudogenes found in a cluster, thought to result from gene duplication, on chromosome 22. Members of the cluster encode proteins that are structurally and functionally related to the C to U RNA-editing cytidine deaminase APOBEC1. The protein encoded by this gene catalyzes site-specific deamination of both RNA and single-stranded DNA. The encoded protein has been found to be a specific inhibitor of human immunodeficiency virus-1 (HIV-1) infectivity. [provided by RefSeq, Mar 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05600 | APOBEC3G Knockout cell line (HCT 116) | Human | APOBEC3G | 1:2~1:4 | Negative | Online Inquiry |
APOBEC3G Gene Knockout Cell Lines are genetically engineered cell lines that have been optimized for the study of the APOBEC3G enzyme, a key component of the innate immune response that provides a defense against viral infections, particularly retroviruses such as HIV. These knockout cell lines have been developed using advanced CRISPR-Cas9 technology to disrupt the gene encoding APOBEC3G, allowing researchers to investigate the functional consequences of its absence and further elucidate its role in viral replication, mutation, and host defense mechanisms.
The primary function of these cell lines is to serve as a model for understanding the implications of APOBEC3G on viral pathogenesis and cellular processes. By comparing the knockout cells with wild-type counterparts, researchers can gain insights into how retroviruses evade immune detection and the impact of APOBEC3G on the mutation rates of viral genomes. This is especially crucial for vaccine development and therapeutic strategies aimed at enhancing antiviral responses.
In the realm of scientific research, these cell lines are essential tools to study HIV-1 evolution, assess drug efficacy, and explore RNA editing processes that catalyze genetic variation in both viral and host DNA. Their application extends into clinical settings where understanding viral dynamics can inform treatment regimens and therapeutic interventions.
APOBEC3G Gene Knockout Cell Lines stand out due to their specificity and the precise genetic editing used in their creation, offering unparalleled reliability compared to traditional models that may not fully mimic the human physiological conditions. Researchers and clinicians can benefit from reduced variability and more accurate experimental outcomes, allowing them to make more informed decisions based on solid evidence.
Ultimately, the value of these cell lines extends beyond mere experimentation; they empower scientists to bridge critical gaps in knowledge about virus-host interactions. Our company specializes in providing high-quality genetic models and has a proven track record in developing reliable biological products that enhance the study of complex biological systems, ensuring researchers have access to state-of-the-art tools to drive their science forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.